tti-0102
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2020 (NCT04262895)
Timeline
Indications
Mechanism of action
- cysteineSupplementation
cysteine supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06644534 | Phase 2 | Nov 30, 2024 | Thiogenesis Therapeutics, Inc. |
| NCT05212662 | Phase 2 | Sep 30, 2022 | Thiogenesis Therapeutics, Inc. |
| NCT04262895 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2020 | Department of Veteran Affairs |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Thiogenesis Therapeutics, Inc. | For profit | 2 | 2 | 1 | 2022 |
| Department of Veteran Affairs | Government | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1